acut
respiratori
infect
ari
common
contribut
significantli
morbid
mortal
lead
caus
outpati
visit
hospit
age
group
especi
children
year
ari
children
outpati
caus
nine
common
respiratori
virus
includ
respiratori
syncyti
viru
rsv
influenza
viru
influenza
viru
b
rhinoviru
adenoviru
parainfluenza
viru
coronaviru
human
metapneumoviru
boca
addit
atyp
pathogen
mycoplasma
pneumonia
also
major
caus
ari
children
symptom
caus
pathogen
larg
similar
thu
definit
diagnosi
requir
effect
laboratori
test
use
multiplex
assay
target
pathogen
earli
diagnosi
made
time
manner
consequenti
antimicrobi
antivir
therapi
may
thu
administr
promptli
importantli
earli
diagnosi
influenza
virus
contagi
benefici
earli
isol
patient
thu
reduc
spread
influenza
virus
routin
clinic
laboratori
test
respiratori
virus
larg
conduct
direct
assay
rapid
antigen
test
china
given
poor
sensit
complic
manual
oper
method
gradual
replac
nucleic
acid
amplif
test
naat
sensit
specif
howev
major
naat
kit
base
polymeras
chain
reaction
pcr
detect
one
two
pathogen
ari
within
singl
tube
thu
syndrom
clinic
econom
impact
syndrom
test
respiratori
pathogen
evalu
sever
studi
overal
implement
syndrom
test
decreas
time
decreas
healthcar
resourc
decreas
inpati
length
stay
time
improv
antivir
use
influenza
surex
respiratori
pathogen
multiplex
kit
resp
syndrom
multiplex
molecular
test
simultan
detect
pathogen
singl
tube
aim
studi
evalu
applic
resp
detect
respiratori
pathogen
outpati
manifest
inclus
criteria
studi
follow
patient
admit
hospit
feb
aug
b
oropharyng
swab
collect
hospit
center
diseas
control
guangzhou
c
patient
follow
manifest
fever
b
cough
sore
throat
sampl
specimen
kept
transfer
laboratori
test
within
one
week
specimen
shaken
vigor
minut
salin
solut
centrifug
g
minut
supernat
aspir
rna
extract
supernat
use
qiaamp
viral
rna
extract
kit
qiagen
hilden
germani
accord
manufactur
instruct
store
influenza
viru
nucleic
acid
detect
perform
influenza
ab
influenza
viru
nucleic
acid
detect
kit
cat
daan
gene
posit
sampl
test
influenza
viru
season
influenza
viru
use
separ
kit
cat
daan
gene
test
carri
abi
quant
studio
system
thermo
fisher
scientif
accord
instruct
typic
amplif
curv
cq
valu
determin
posit
influenza
sampl
pcr
test
perform
detect
follow
pathogen
adenoviru
adv
bocaviru
bov
human
rhinoviru
hrv
parainfluenza
viru
piv
human
metapneumoviru
hmpv
mycoplasma
pneumonia
mp
respiratori
syncyti
viru
rsv
use
correspond
naat
kit
daan
gene
test
carri
abi
quant
studio
system
thermo
fisher
scientif
accord
instruct
typic
amplif
curv
cq
valu
determin
posit
nucleic
acid
subject
multiplex
amplif
specimen
use
surex
respiratori
pathogen
multiplex
detect
kit
cat
ningbo
health
gene
technolog
abi
geneamp
pcr
system
thermo
fisher
scientif
respiratori
pathogen
follow
influenza
viru
influenza
viru
season
influenza
viru
influenza
b
viru
adenoviru
boca
viru
rhinoviru
parainfluenza
viru
chlamydia
human
metapneumoviru
mycoplasma
pneumonia
coronaviru
respiratori
syncyti
viru
pcr
product
subject
capillari
electrophoresi
use
gexp
genet
analysi
system
beckman
coulter
accord
instruct
pathogen
detect
produc
distinct
fragment
size
pcr
amplif
result
fragment
analysi
use
determin
outcom
test
brief
peak
height
target
fragment
size
lower
lower
peak
signal
standard
target
pathogen
determin
neg
peak
height
target
fragment
size
higher
higher
peak
signal
standard
target
pathogen
determin
posit
peak
height
target
fragment
size
higher
lower
peak
signal
standard
target
pathogen
determin
uncertain
test
repeat
result
analyz
use
cohen
kappa
statist
calcul
measur
agreement
pcr
multiplex
pcr
result
poor
slight
fair
moder
substanti
almost
perfect
p
valu
calcul
chitest
p
indic
statist
signific
total
oropharyng
swab
enrol
hospit
cdc
guangzhou
sampl
collect
wide
rang
age
averag
age
tabl
specimen
male
result
determin
fragment
posit
shown
figur
neg
result
determin
none
fragment
posit
control
hudna
hurna
ic
posit
figur
studi
resp
detect
posit
result
sampl
account
compar
test
detect
posit
result
sampl
posit
rate
among
detect
pathogen
rhinoviru
common
follow
adenoviru
influenza
viru
tabl
specimen
resp
yield
consist
posit
result
specimen
consist
neg
result
specimen
compar
pcr
lead
overal
agreement
specimen
detect
posit
coronaviru
chlamydia
six
ten
detect
pathogen
cohen
kappa
valu
p
valu
tabl
lowest
kappa
observ
human
metapneumoviru
multiplex
naat
increasingli
use
syndrom
diagnosi
due
high
throughput
high
sensit
high
specif
great
clinic
resp
assay
base
multiplex
pcr
amplif
capillari
electrophoret
separ
pcr
amplicon
length
techniqu
use
pathogen
detect
subtyp
classif
pediatr
acut
lymphoblast
compar
result
standard
size
marker
target
pathogen
pathogen
sampl
separ
identifi
subtyp
virus
design
distinguish
assay
except
influenza
viru
influenza
viru
two
subtyp
popular
china
recent
therefor
patient
whose
specimen
posit
influenza
viru
neg
influenza
viru
probabl
infect
uncommon
influenza
viru
avian
influenza
viru
immedi
quarantin
confirm
note
hospit
cdc
first
reach
patient
assay
help
hospit
identifi
patient
make
appropri
quarantin
measur
time
manner
control
spread
avian
influenza
viru
assay
previous
clinic
appli
detect
respiratori
pathogen
hospit
children
suffer
pneumonia
cap
lower
respiratori
tract
assay
evalu
compar
sanger
sequenc
show
great
perform
posit
predict
valu
ppv
neg
predict
valu
npv
knowledg
first
studi
evalu
perform
resp
oropharyng
swab
specimen
outpati
ari
studi
show
almost
perfect
kappa
statist
resp
rhinoviru
adenoviru
influenza
viru
respiratori
syncyti
viru
influenza
viru
b
suggest
perform
resp
virus
effect
pcr
human
metapneumoviru
kappa
statist
lower
presum
due
small
number
posit
case
overal
assay
demonstr
ppv
npv
work
suggest
perform
resp
suffici
enough
use
respiratori
pathogen
identif
outpati
manifest
major
limit
studi
small
number
human
metapneumoviru
parainfluenza
viru
mycoplasma
pneumonia
boca
viru
influenza
viru
coronaviru
chlamydia
investig
need
evalu
perform
resp
pathogen
conclus
perform
resp
show
agreement
pcr
oropharyng
swab
outpati
implement
resp
may
facilit
diagnosi
respiratori
infect
varieti
clinic
scenario
studi
support
grant
nation
scienc
technolog
major
project
ministri
scienc
technolog
china
project
key
medicin
disciplin
construct
guangzhou
municip
scienc
technolog
program
guangdong
health
depart
scienc
technolog
program
guangzhou
health
depart
